entinostat (SNDX-275) - Kyowa Hakko Kirin, Syndax
Entinostat: NDA submission for advanced HR+, HER2- breast cancer in 2020 (Syndax) - May 7, 2019 - Q1 2019 Results 
NDA
http://ir.syndax.com/events-presentations
 
May 7, 2019
 
 
652f846a-63c3-4e3d-a084-a683e03bedd3.png